Cargando…
Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment
Autores principales: | Jin, Tianru, Liu, Mingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255283/ https://www.ncbi.nlm.nih.gov/pubmed/32834951 http://dx.doi.org/10.1016/j.apsb.2020.05.006 |
Ejemplares similares
-
Comment on Letter to the Editor
por: Dettori, Joseph R., et al.
Publicado: (2020) -
Comment/response to letter to editor
por: Ayoub, Elias
Publicado: (2021) -
Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
por: Pang, Juan, et al.
Publicado: (2021) -
Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
por: Zhou, Zeqi, et al.
Publicado: (2021) -
Reply to the Letter to the Editor: Comment on “COVID-19 infection control protocol inside computed tomography suites”
por: Yamashiro, Tsuneo, et al.
Publicado: (2020)